curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 15,150
-250 (-1.62%)
At close: May 14, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 322.76 billion as of May 15, 2026. Its market cap has increased by 244.35% in one year.
Market Cap
322.76B
Enterprise Value
312.08B
Revenue
7.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
15,150.00
Market Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 322.76B, a decrease of -21.16%. That is a compound annual growth rate of -4.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 328.08B | 119.02% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | 409.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 491.22B |
| S.Biomedics | 387.65B |
| Kanaph Therapeutics | 364.64B |
| Kangstem Biotech | 328.72B |
| HansBiomed | 328.01B |
| Y-Biologics | 320.26B |
| TiumBio | 302.06B |
| NIBEC | 254.07B |